1
|
Kintner J, Callaghan M, Bulawa L, Chu A, Ma Z, Williams DL, Schoborg RV, Kruppa MD, Hall JV. Dectin-1 stimulating β-glucans inhibit Chlamydia infections both in vitro and in vivo. Pathog Dis 2025; 83:ftaf002. [PMID: 39886876 PMCID: PMC11840957 DOI: 10.1093/femspd/ftaf002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2024] [Revised: 01/03/2025] [Accepted: 01/27/2025] [Indexed: 02/01/2025] Open
Abstract
Chlamydia trachomatis and Candida albicans are common inhabitants of the female genital tract. Candida albicans can impact the viability and pathogenesis of some bacteria. Previously, we investigated physical interactions between Ch. trachomatis elementary bodies (EBs) and Ca. albicans. This work indicated that EBs bind to Ca. albicans and become noninfectious by 24 h post-binding. Here, we continue our investigation of these interkingdom, polymicrobial interactions. Candida albicans adheres to bacteria or host surfaces via agglutinin-like sequence or heat shock 70 (Ssa) proteins. Chlamydia trachomatis EBs did not bind Ca. albicans Ssa2 deficient strains as efficiently as wild-type or complemented strains, indicating a role for this protein in chlamydial adherence to Candida. Additionally, Ca. albicans β-glucans inhibit chlamydial infection when exposure occurs during EB adsorption onto cervical cells. Laminarin, a β-glucan agonist of the C-type lectin receptor Dectin-1, inhibited chlamydial infection in both cervical epithelial cells and mice when exposure occurred prior to, during, or immediately following EB inoculation. Conversely, a Dectin-1 antagonist laminarin did not inhibit infection in vitro, suggesting that β-glucan inhibition of Ch. trachomatis requires C-type lectin receptor signaling. Overall, our data demonstrate that β-glucans from multiple species, including Ca. albicans, inhibit Chlamydia via stimulation of host-signaling pathways.
Collapse
Affiliation(s)
- Jennifer Kintner
- Department of Biomedical Sciences, East Tennessee State University, Johnson City, TN 37614, USA
- Center for Infectious Disease, Inflammation and Immunity, East Tennessee State University, Johnson City, TN 37614, USA
| | - Morgan Callaghan
- Department of Biomedical Sciences, East Tennessee State University, Johnson City, TN 37614, USA
| | - Lillith Bulawa
- Department of Biomedical Sciences, East Tennessee State University, Johnson City, TN 37614, USA
| | - Angela Chu
- Department of Biomedical Sciences, East Tennessee State University, Johnson City, TN 37614, USA
| | - Zuchao Ma
- Center for Infectious Disease, Inflammation and Immunity, East Tennessee State University, Johnson City, TN 37614, USA
- Department of Surgery, East Tennessee State University, Johnson City, TN 37614, USA
| | - David L Williams
- Center for Infectious Disease, Inflammation and Immunity, East Tennessee State University, Johnson City, TN 37614, USA
- Department of Surgery, East Tennessee State University, Johnson City, TN 37614, USA
| | - Robert V Schoborg
- Center for Infectious Disease, Inflammation and Immunity, East Tennessee State University, Johnson City, TN 37614, USA
- Department of Medical Education at Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, USA
| | - Michael D Kruppa
- Department of Biomedical Sciences, East Tennessee State University, Johnson City, TN 37614, USA
- Center for Infectious Disease, Inflammation and Immunity, East Tennessee State University, Johnson City, TN 37614, USA
| | - Jennifer V Hall
- Department of Biomedical Sciences, East Tennessee State University, Johnson City, TN 37614, USA
- Center for Infectious Disease, Inflammation and Immunity, East Tennessee State University, Johnson City, TN 37614, USA
| |
Collapse
|
2
|
Jørgensen MR. Pathophysiological microenvironments in oral candidiasis. APMIS 2024; 132:956-973. [PMID: 38571459 DOI: 10.1111/apm.13412] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2024] [Accepted: 03/20/2024] [Indexed: 04/05/2024]
Abstract
Oral candidiasis (OC), a prevalent opportunistic infection of the oral mucosa, presents a considerable health challenge, particularly in individuals with compromised immune responses, advanced age, and local predisposing conditions. A considerable part of the population carries Candida in the oral cavity, but only few develop OC. Therefore, the pathogenesis of OC may depend on factors other than the attributes of the fungus, such as host factors and other predisposing factors. Mucosal trauma and inflammation compromise epithelial integrity, fostering a conducive environment for fungal invasion. Molecular insights into the immunocompromised state reveal dysregulation in innate and adaptive immunity, creating a permissive environment for Candida proliferation. Detailed examination of Candida species (spp.) and their virulence factors uncovers a nuanced understanding beyond traditional C. albicans focus, which embrace diverse Candida spp. and their strategies, influencing adhesion, invasion, immune evasion, and biofilm formation. Understanding the pathophysiological microenvironments in OC is crucial for the development of targeted therapeutic interventions. This review aims to unravel the diverse pathophysiological microenvironments influencing OC development focusing on microbial, host, and predisposing factors, and considers Candida resistance to antifungal therapy. The comprehensive approach offers a refined perspective on OC, seeking briefly to identify potential therapeutic targets for future effective management.
Collapse
Affiliation(s)
- Mette Rose Jørgensen
- Section of Oral Pathology and Oral Medicine, Department of Odontology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
| |
Collapse
|
3
|
Kumar D, Kumar A. Cellular Attributes of Candida albicans Biofilm-Associated in Resistance Against Multidrug and Host Immune System. Microb Drug Resist 2023; 29:423-437. [PMID: 37428599 DOI: 10.1089/mdr.2022.0347] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/12/2023] Open
Abstract
One of the ubiquitous hospital-acquired infections is associated with Candida albicans fungus. Usually, this commensal fungus causes no harm to its human host, as it lives mutually with mucosal/epithelial tissue surface cells. Nevertheless, due to the activity of various immune weakening factors, this commensal starts reinforcing its virulence attributes with filamentation/hyphal growth and building an absolute microcolony composed of yeast, hyphal, and pseudohyphal cells, which is suspended in an extracellular gel-like polymeric substance (EPS) called biofilms. This polymeric substance is the mixture of the secreted compounds from C. albicans as well as several host cell proteins. Indeed, the presence of these host factors makes their identification and differentiation process difficult by host immune components. The gel-like texture of the EPS makes it sticky, which adsorbs most of the extracolonial compounds traversing through it that aid in penetration hindrance. All these factors further contribute to the multidrug resistance phenotype of C. albicans biofilm that is spotlighted in this article. The mechanisms it employs to escape the host immune system are also addressed effectively. The article focuses on cellular and molecular determinants involved in the resistance of C. albicans biofilm against multidrug and the host immune system.
Collapse
Affiliation(s)
- Dushyant Kumar
- Department of Biotechnology, National Institute of Technology, Raipur, India
| | - Awanish Kumar
- Department of Biotechnology, National Institute of Technology, Raipur, India
| |
Collapse
|